The Boston startup uses AI to translate and verify legacy software for defense contractors, arguing modernization can’t come at the cost of new bugs.
Structure Therapeutics Inc. is emerging in oral GLP-1 obesity drugs after Phase II success and rivals’ setbacks. Click here ...
This study presents a potentially valuable exploration of the role of thalamic nuclei in language processing. The results will be of interest to researchers interested in the neurobiology of language.
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Optimizing Your LinkedIn Profile for Element Materials Technology So, you’re looking to make a splash at Element ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results